Elucidating Tumor Heterogeneity from Spatially Resolved Transcriptomics in ALK-Rearranged Non-small Cell Lung Cancer

被引：0
|
作者：
Oh, J. [1 ,2 ]
Lee, M. -S. [1 ,2 ]
Jeong, H. [1 ,2 ]
Choi, Y. -L. [2 ,3 ,4 ]
机构：
[1] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea
[2] Sungkyunkwan Univ S, Samsung Med Ctr, Lab Mol Pathol & Theranost, ch Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Dept Pathol & Translat Genom, Samsung Med Ctr, Sch Med, Seoul, South Korea
[4] Sungkyunkwan Univ, Dept Pathol & Translat Genom, Samsung Med Ctr, Sch Med, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
基金：
新加坡国家研究基金会;
关键词：
ALK-rearranged NSCLC; Spatial transcriptomics; Heterogeneity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP06.03-02
引用
收藏
页码：S482 / S483
页数：2
相关论文
共 50 条
  • [1] Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancer
    Schmid, Sabine
    Garcia, Miguel
    Cheng, Sierra
    Zhan, Luna
    Chotai, Simren
    Balaratnam, Karmugi
    Khan, Khaleeq
    Patel, Devalben
    Brown, M. Catherine
    Sachdeva, Robin
    Xu, Wei
    Shepherd, Frances A.
    Sacher, Adrian
    Leighl, Natasha B.
    Bradbury, Penelope
    Moriarty, Patrick
    Kuruvilla, M. Sara
    Liu, Geoffrey
    LUNG CANCER, 2022, 166 : 58 - 62
  • [2] Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer
    Kitadai, Rui
    Okuma, Yusuke
    Kashima, Jumpei
    CASE REPORTS IN ONCOLOGY, 2019, 12 (01): : 171 - 177
  • [3] Transition of HSP90-Dependent Client Proteins in ALK Rearranged Non-Small Cell Lung Cancer
    Yoshida, Ryohei
    Okumura, Shunsuke
    Sasaki, Takaaki
    Ohsaki, Yoshinobu
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S694 - S695
  • [4] Response to Crizotinib Re-administration After Progression on Lorlatinib in a Patient With ALK-rearranged Non-small-cell Lung Cancer
    Sakakibara-Konishi, Jun
    Kitai, Hidenori
    Ikezawa, Yasuyuki
    Hatanaka, Yutaka
    Sasaki, Takaaki
    Yoshida, Ryohei
    Chiba, Shinichi
    Matsumoto, Shingo
    Goto, Koichi
    Mizugaki, Hidenori
    Shinagawa, Naofumi
    CLINICAL LUNG CANCER, 2019, 20 (05) : E555 - E559
  • [5] Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer
    Kron, A.
    Alidousty, C.
    Scheffler, M.
    Merkelbach-Bruse, S.
    Seidel, D.
    Riedel, R.
    Ihle, M. A.
    Michels, S.
    Nogova, L.
    Fassunke, J.
    Heydt, C.
    Kron, F.
    Ueckeroth, F.
    Serke, M.
    Krueger, S.
    Grohe, C.
    Koschel, D.
    Benedikter, J.
    Kaminsky, B.
    Schaaf, B.
    Braess, J.
    Sebastian, M.
    Kambartel, K. -O.
    Thomas, R.
    Zander, T.
    Schultheis, A. M.
    Buettner, R.
    Wolf, J.
    ANNALS OF ONCOLOGY, 2018, 29 (10) : 2068 - 2075
  • [6] Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer
    Zhou, Xiaoyun
    Shou, Jiawei
    Sheng, Jin
    Xu, Chunwei
    Ren, Shengxiang
    Cai, Xiuyu
    Chu, Qian
    Wang, Wenxian
    Zhen, Qinhong
    Zhou, Yuefen
    Li, Wenfeng
    Pan, Hong
    Li, Hongsen
    Sun, Tao
    Cheng, Huanqing
    Wang, Huina
    Lou, Feng
    Rao, Chuangzhou
    Cao, Shanbo
    Pan, Hongming
    Fang, Yong
    CANCER SCIENCE, 2019, 110 (10) : 3382 - 3390
  • [7] Investigation on the survival implications of PD-L1 expression status in ALK-rearranged advanced non-small cell lung cancer treated with first-line crizotinib
    Zhou, Yuling
    Song, Lianxi
    Xu, Qinqin
    Zeng, Liang
    Jiang, Wenjuan
    Yang, Nong
    Zhang, Yongchang
    LUNG CANCER, 2022, 167 : 58 - 64
  • [8] Tumor heterogeneity and its impact on sotorasib response in a patient with non-small cell lung cancer
    Nalewaj, Karolina P.
    Chmielewska, Izabela
    Krawczyk, Pawel
    Grenda, Anna
    Grzycka-Kowalik, Luiza
    Pasnik, Iwona
    Milanowski, Janusz
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (05): : 351 - 358
  • [9] Proposal to Revise VENTANA ALK Scoring Interpretation Guide for Non-Small Cell Lung Carcinoma: Interpretation of ALK Heterogeneity
    Yan, L.
    Cui, Q.
    Luo, D.
    Ge, Y.
    Chen, J.
    Li, Z.
    Wu, Y.
    Liu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S783 - S784
  • [10] Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for Immunotherapy
    Oh, Michael S.
    Abascal, Jensen
    Rennels, Austin K.
    Salehi-Rad, Ramin
    Dubinett, Steven M.
    Liu, Bin
    CANCERS, 2025, 17 (06)
12345